Growth through M&A NIRx was acquired by Gilde Healthcare in 2025, signaling a broader capital backing and potential channel and distribution expansion. This creates opportunities to align with new strategic priorities, expand into additional markets, and access a larger network of customers and partners.

Product Expansion Recent launches such as Satori 2.0 and NIRxWINGS2 indicate a strong product roadmap and ongoing innovation in data preprocessing, visualization, and multimodal sensing. Use these to position upgraded value propositions to research labs upgrading their fNIRS capabilities.

Strategic Partnerships Partnerships with Brain Innovation and Artinis reflect a collaborative approach to technology integration. Explore co-sell or bundled offerings with partners to reach broader neuroscience and clinical research audiences.

Global Presence With offices in Orlando and Berlin and active EU and US support lines, there is a dual-market reach. This supports targeting both North American and European research institutions for hardware, software, and training solutions.

Education and Support A robust learning center and training programs position NIRx as a trusted knowledge partner. Leverage training and technical support as a differentiator to upsell analytics software, consulting, and ongoing service contracts.